Hosted on MSN7mon
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma GiantAtai Life Sciences (NASDAQ:ATAI) announced promising preliminary results on Tuesday for its DMT-based depression therapy ... Johnson's ketamine-based depression drug, Spravato.
(KNSI) - A husband and wife appeared in Sherburne County District Court Friday after being arrested for allegedly running a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results